GlaxoSmithKline shuts down plant over legionnaires' bacteria

Pharmaceutical giant GlaxoSmithKline has shut down a US plant that produces inhaled medications after discovering the bacteria that causes Legionnaires’ disease.

GlaxoSmithKline shuts down plant over legionnaires' bacteria

Pharmaceutical giant GlaxoSmithKline has shut down a US plant that produces inhaled medications after discovering the bacteria that causes Legionnaires’ disease.

The manufacturing plant in Zebulon, about 25 miles east of Raleigh, North Carolina, was closed after routine testing found the bacteria in a self-standing cooling tower.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited